Table 1.

Immunophenotypic and Karyotypic Features of 27 Patients With ALL

Patient No. Age (yr) Immunophenotype-151Karyotype
1-150 5  Early B 46,XY,t(9;22)(q34;q11.2)[19]  
2  8  Early B 46,XY,t(9;22)(q34;q11.2)[23]-152 
3-150 Early B  46,XY,t(9;22)(q34;q11.2)[16]-152 
4-150 14  Pre-B  46,XX,t(4;11)(q21;q23)[22]  
5  15 Pre-B 47,XY,+X,t(4;11)(q21;q23)[10]/46,idem,−X[9]/46,XY[5]-152 
6  <1  Pre-B 46,XY,t(4;11)(q21;q23)[11]/46,XY[10]-152 
7  Early B  47,XY,+X,t(11;19)(q23;p13.3)[22]/46,XY[4]-152 
8  3  Early B  46,XX[31]-152 
9  2  Pre-B 46,XY,add(8)(p21)[10]/46,XY,t(9;11)(p22;q23)[1]/46,XY[4]-152 
10  8  Early B 46,XY,del(9)(p13),t(9;18)(p13;q11)[12]/46,XY[16]  
11 4  Early B  47,XY,+21[3]/46,XY,del(9)(p21)[2] 
12  8  Early B 29,XY,+4,+8,+18,+21,+mar[5]/57,XY,+X,+?Y,+4,+5,del(5)(p13),?del(6)(q21), +6,+8,+9,+14,+18,+21,+mar[6]  
13  15  Pre-B 46,XY,del(3)(q21q26)[9]/46,XY[5]  
14  6  Pre-B 47,XX,+10,del(11)(q23),t(1;12)(p22;p13),t(4;12)(q21;p13)[7]/45,X,−X, t(4;12)(q21;p13)[2]-152 
15  1  Early B 45,XX,−7,del(1)(q32),der(12)t(7;12)(q11;p13)[10]/46,XX[8]-152 
16  14  Early B  46,XX[23]  
17  14 Early B  46,XX,del(11)(q23)[4]/46,XX[24]-152 
18 3  Early B  46,XX,add(21)(p11)[10]/46,XX[10]  
19 8  Early B 46,XX,t(8;9)(q12-13;p22),t(15;19)(q15;p13)[19]/46,idem,−14,+mar[1] 
20  3  Early B 48,XY,+10,add(12)(p13),+21[22]/46,XY[4]-152 
21  Early B  47,XY,add(19)(p13),+21[8]/46,XY[17]  
22 5  T  46,XY,add(19)(p13)[5]/46,XY[12]  
23  12 T  46,XY[50]  
24  4  45,XY,del(11)(q14q23),add(12)(p11.2),−18[11]/45,idem, der(16)t(1;16)(q21;q11.2)[5]  
25  4  T  ND 
26  16  T  46,XY,del(6)(q15q21)[5]/46,XY[5] 
27  12  T  46,XX[29] 
Patient No. Age (yr) Immunophenotype-151Karyotype
1-150 5  Early B 46,XY,t(9;22)(q34;q11.2)[19]  
2  8  Early B 46,XY,t(9;22)(q34;q11.2)[23]-152 
3-150 Early B  46,XY,t(9;22)(q34;q11.2)[16]-152 
4-150 14  Pre-B  46,XX,t(4;11)(q21;q23)[22]  
5  15 Pre-B 47,XY,+X,t(4;11)(q21;q23)[10]/46,idem,−X[9]/46,XY[5]-152 
6  <1  Pre-B 46,XY,t(4;11)(q21;q23)[11]/46,XY[10]-152 
7  Early B  47,XY,+X,t(11;19)(q23;p13.3)[22]/46,XY[4]-152 
8  3  Early B  46,XX[31]-152 
9  2  Pre-B 46,XY,add(8)(p21)[10]/46,XY,t(9;11)(p22;q23)[1]/46,XY[4]-152 
10  8  Early B 46,XY,del(9)(p13),t(9;18)(p13;q11)[12]/46,XY[16]  
11 4  Early B  47,XY,+21[3]/46,XY,del(9)(p21)[2] 
12  8  Early B 29,XY,+4,+8,+18,+21,+mar[5]/57,XY,+X,+?Y,+4,+5,del(5)(p13),?del(6)(q21), +6,+8,+9,+14,+18,+21,+mar[6]  
13  15  Pre-B 46,XY,del(3)(q21q26)[9]/46,XY[5]  
14  6  Pre-B 47,XX,+10,del(11)(q23),t(1;12)(p22;p13),t(4;12)(q21;p13)[7]/45,X,−X, t(4;12)(q21;p13)[2]-152 
15  1  Early B 45,XX,−7,del(1)(q32),der(12)t(7;12)(q11;p13)[10]/46,XX[8]-152 
16  14  Early B  46,XX[23]  
17  14 Early B  46,XX,del(11)(q23)[4]/46,XX[24]-152 
18 3  Early B  46,XX,add(21)(p11)[10]/46,XX[10]  
19 8  Early B 46,XX,t(8;9)(q12-13;p22),t(15;19)(q15;p13)[19]/46,idem,−14,+mar[1] 
20  3  Early B 48,XY,+10,add(12)(p13),+21[22]/46,XY[4]-152 
21  Early B  47,XY,add(19)(p13),+21[8]/46,XY[17]  
22 5  T  46,XY,add(19)(p13)[5]/46,XY[12]  
23  12 T  46,XY[50]  
24  4  45,XY,del(11)(q14q23),add(12)(p11.2),−18[11]/45,idem, der(16)t(1;16)(q21;q11.2)[5]  
25  4  T  ND 
26  16  T  46,XY,del(6)(q15q21)[5]/46,XY[5] 
27  12  T  46,XX[29] 

Abbreviation: ND, not determined.

F0-150

Studied at relapse.

F0-151

Early B: CD19+, CD10+ or CD10; Pre-B: same, but with cytoplasmic μ; T: CD7+, cytoplasmic or surface CD3+.

F0-152

Karyotypes previously reported.

or Create an Account

Close Modal
Close Modal